Literature DB >> 7870630

Thalidomide--the way forward.

J M Gardner-Medwin1, R J Powell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870630      PMCID: PMC2398026          DOI: 10.1136/pgmj.70.830.860

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  31 in total

1.  Thalidomide for systemic lupus erythematosus.

Authors:  D F Hawkins
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

2.  The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies.

Authors:  G W MELLIN; M KATZENSTEIN
Journal:  N Engl J Med       Date:  1962-12-13       Impact factor: 91.245

3.  Neuropathy after intake of thalidomide (distaval).

Authors:  P M FULLERTON; M KREMER
Journal:  Br Med J       Date:  1961-09-30

4.  [N-phthalyl-glutamic acid imide; experimental studies on a new synthetic product with sedative properties].

Authors:  H KELLER; W KUNZ; H MUCKTER
Journal:  Arzneimittelforschung       Date:  1956-08

5.  Aphthous ulcers in HIV-infected patients: treatment with thalidomide.

Authors:  S Strazzi; C Lebbe; C Geoffray; G Ablon; P Morel; O Verola; J M Molina
Journal:  Genitourin Med       Date:  1992-12

6.  Thalidomide to treat esophageal ulcer in AIDS.

Authors:  J Ryan; J Colman; J Pedersen
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

7.  Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217).

Authors:  H Larsson
Journal:  J Intern Med       Date:  1990-10       Impact factor: 8.989

8.  [Thalidomide embryopathy].

Authors:  W LENZ; K KNAPP
Journal:  Dtsch Med Wochenschr       Date:  1962-06-15       Impact factor: 0.628

9.  Thalidomide inhibits the replication of human immunodeficiency virus type 1.

Authors:  S Makonkawkeyoon; R N Limson-Pobre; A L Moreira; V Schauf; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine.

Authors:  F Tamura; G B Vogelsang; B A Reitz; W A Baumgartner; A Herskowitz
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.